BlackRock, Inc. 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 66,977 1.800% | -169,345 (-71.66%) | Filing |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 236,322 6.200% | -9,246 (-3.77%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Athira Pharma, Inc. ATHA | BlackRock Inc. BLK | 245,568 6.600% | 245,568 (New Position) | Filing |